GLOBAL INDEMNITY GROUP, LLC financials

GBLI CIK 0001494904

Source: EDGAR filings · Built 2026-06-19T02:25:45Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Debt -57.21M -6.64M -25.30M -23.14M 67.23M 81.88M
Net Margin 5.63% 9.80% 4.81% -0.14% 4.33% -3.60%
Return on Equity (ROE) 3.59% 6.27% 3.92% -0.14% 4.15% -2.92%
Return on Assets (ROA) 1.47% 2.50% 1.47% -0.05% 1.46% -1.10%
Debt-to-Equity 0.01× 0.01× 0.02× 0.03× 0.21× 0.21×
Effective Tax Rate 23.92% 21.32% 22.89% 143.13% 10.51% 27.84%
Cash Conversion Ratio 0.36× 0.90× 1.69× -52.04× 3.09× -1.56×
Accruals Ratio 0.01× 0.00× -0.01× -0.03× -0.03× -0.03×
SBC % of Revenue 1.36% 1.08% 0.66% 0.62% 0.35% 1.16%

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 450.10M 441.19M 528.13M 628.53M 678.27M 583.55M
Income Tax Expense (Benefit) 7.96M 11.71M 7.55M 2.82M 3.45M -8.11M
Net Income (Loss) Attributable to Parent 25.33M 43.24M 25.43M -850.00K 29.35M -21.01M
Earnings Per Share, Basic $1.75 $3.14 $1.84 $-0.09 $2.00 $-1.48
Weighted Average Number of Shares Outstanding, Basic 14.19M 13.64M 13.55M 14.48M 14.43M 14.29M
Earnings Per Share, Diluted $1.75 $3.12 $1.83 $-0.09 $1.97 $-1.48
Weighted Average Number of Shares Outstanding, Diluted 14.26M 13.71M 13.67M 14.48M 14.66M 14.29M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 65.54M 17.01M 38.04M 38.85M 78.28M 67.36M
Assets 1.72B 1.73B 1.73B 1.80B 2.01B 1.90B
Long-term Debt 0 126.43M 126.29M
Liabilities 1.01B 1.04B 1.08B 1.17B 1.31B 1.19B
Stockholders' Equity Attributable to Parent 706.59M 689.15M 648.75M 626.23M 706.62M 718.32M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 9.06M 38.84M 42.89M 44.24M 90.80M 32.67M
Net Cash Provided by (Used in) Investing Activities 59.91M -39.51M -16.33M 80.13M -64.52M 174.59M
Payments for Repurchase of Common Stock 0 529.00K 12.68M 22.34M 490.00K 153.00K
Net Cash Provided by (Used in) Financing Activities -20.44M -20.36M -27.36M -163.80M -15.36M -184.17M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GBLI CIK 0001494904), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

GLW

CORNING INC /NY

PRRUF

Immutep Limited

AMGN

Amgen Inc.